• Daunorubicin is in the anthracycline family of medication. (wikipedia.org)
  • An anthracycline antineoplastic agent, daunorubicin inhibits DNA and RNA synthesis by intercalating between DNA base pairs. (medscape.com)
  • Daunorubicin injection must be given in a hospital or medical facility under the supervision of a doctor who is experienced in giving chemotherapy medications for cancer. (medlineplus.gov)
  • Daunorubicin comes as a solution (liquid) or as a powder to be mixed with liquid to be injected intravenously (into a vein) by a doctor or nurse in a medical facility along with other chemotherapy medications. (medlineplus.gov)
  • Daunorubicin, also known as daunomycin, is a chemotherapy medication used to treat cancer. (wikipedia.org)
  • Daunorubicin can cause a severe decrease in the number of blood cells in your bone marrow. (medlineplus.gov)
  • Daunorubicin may cause serious or life-threatening heart problems at any time during your treatment or months to years after your treatment has ended. (medlineplus.gov)
  • Your doctor will order tests before and during your treatment to see if your heart is working well enough for you to safely receive daunorubicin. (medlineplus.gov)
  • Daunorubicin was approved for medical use in the United States in 1979. (wikipedia.org)
  • Daunorubicin injection must be given in a hospital or medical facility under the supervision of a doctor who is experienced in giving chemotherapy medications for cancer. (medlineplus.gov)
  • Daunorubicin comes as a solution (liquid) or as a powder to be mixed with liquid to be injected intravenously (into a vein) by a doctor or nurse in a medical facility along with other chemotherapy medications. (medlineplus.gov)
  • Daunorubicin, also known as daunomycin, is a chemotherapy medication used to treat cancer. (wikipedia.org)
  • Daunorubicin has been used with other chemotherapy agents to treat the blastic phase of chronic myelogenous leukemia. (wikipedia.org)
  • Chemotherapy with daunorubicin in combination with other agents is associated with serum enzyme elevations in a proportion of patients depending upon the dose and other agents used. (nih.gov)
  • Cancer treatments, from surgery, radiation therapy and chemotherapy to drugs such as daunorubicin (Cerubidine and DaunoXome) and Ixempra (ixabepilone) will all take a toll on the skin - after all, it is the body's largest organ. (paiskincare.us)
  • Daunorubicin should only be administered in a rapid intravenous infusion. (wikipedia.org)
  • Daunorubicin is an anthracycline antibiotic that has antineoplastic activity and is used in the therapy of acute leukemia and AIDS related Kaposi sarcoma. (nih.gov)
  • Daunorubicin has potent activity in acute leukemia and was approved for this indication in the United States in 1979. (nih.gov)
  • ALT elevations during daunorubicin therapy are usually asymptomatic and transient and may resolve without dose modification. (nih.gov)
  • Daunorubicin ends when the third dose is given on Day 3. (chemoexperts.com)
  • See the "Daunorubicin Precautions" section. (rxwiki.com)
  • Daunorubicin is given intravenously, typically in a regimen of once daily for 3 days during induction and for two days of subsequent courses. (nih.gov)
  • However, high doses of daunorubicin given in combination with other antineoplastic agents have been linked to cases of sinusoidal obstruction syndrome, typically presenting with right upper quadrant pain 10 to 30 days after the infusion, followed by weight gain, ascites and liver test abnormalities. (nih.gov)
  • Daunorubicin is an anthracycline that intercalates with DNA and interferes with DNA synthesis. (medscape.com)
  • Daunorubicin (daw" noe roo' bi sin) is a parenterally administered, cytotoxic antibiotic which is believed to act by intercalating between DNA base pairs and uncoiling the DNA helix, which results in inhibition of DNA synthesis and apoptosis of rapidly dividing cells. (nih.gov)
  • Small volumes of daunorubicin can be wrapped up in these minuscule pods, which can then be released into a leukemia cell-filled environment. (wikipedia.org)
  • Daunorubicin is a prescription medication used to treat certain types of blood cancer, such as leukemia, in combination with other approved anticancer drugs. (rxwiki.com)
  • Daunorubicin can cause a severe decrease in the number of blood cells in your bone marrow. (medlineplus.gov)
  • Local extravasation of daunorubicin causes severe local tissue injury. (nih.gov)
  • Daunorubicin is associated with a low rate of transient serum enzyme and bilirubin elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury with jaundice. (nih.gov)
  • There have been no convincing instances of acute, clinically apparent idiosyncratic liver injury with jaundice associated with daunorubicin therapy. (nih.gov)
  • Daunorubicin has been used intravitreally (inside the eye) for the purposes of preventing proliferative vitreoretinopathy, a common complication following retinal detachment surgery, but has not been found to be effective and is not used for any other ophthalmic purposes at this time. (wikipedia.org)
  • Daunorubicin treats certain types of blood cancer. (rxwiki.com)
  • In many instances, it is difficult to attribute the liver test abnormalities to daunorubicin, because of the exposure to other potentially hepatotoxic agents. (nih.gov)